BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Human chorionic gonadotropin
,
Bleomycin
,
rs2300478
,
MYC
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ganoderma
Summary
General Info
Curated Studies
Most Correlated Studies
Effects of Ganoderma lucidum polysaccharides F3 on leukemia cell line THP-1
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural diversity, hypothetical biosynthesis, chemical synthesis, and biological activity of Gano…
Unified Total Synthesis of Diverse Meroterpenoids from Ganoderma Applanatum.
Isolation and Characterization of trans-p-Hydroxycinnamoyl Meroterpenoids from Ganoderma sinensis.
The Phytochemistry of Ganoderma Species and their Medicinal Potentials.
Integrating machine learning and electrochemistry to develop a glucose biosensor assembled with Gano…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Effect of Ganoderma on Patients With Head-and-neck Cancer
Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of …
Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers
Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis
Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of O…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ